SARS-CoV-2 Antigen Rapid Test

Providing an aid in early diagnosis of individuals who are suspected of COVID-19 by their healthcare provider and who are asymptomatic.

To contact us please click here!
News
Location:Home > ABOUT US > News
未标题-2.jpg
Apr. 9, 2021 – ACON, one of the professional in-vitro diagnostic products manufacturers, announced today that its Flowflex SARS-CoV-2 Antigen Rapid Test has been approved for Self-testing use in...
View Details
未标题-2.jpg
Hangzhou, China, Apr. 8, 2021 – ACON, one of the professional in-vitro diagnostic products manufacturers, announced today that its Flowflex SARS-CoV-2 Antigen Rapid Test has been granted for ...
View Details
未标题-2.jpg
Hangzhou, China, March 23, 2021 – ACON, one of the professional in-vitro diagnostic products manufacturers, announced today that its Flowflex SARS-CoV-2 Antigen Rapid Test has passed the com...
View Details
图片-FIA-01.png
We are pleased to announce that the FIAflex Fluorescent Immunoassay Systemproduct series was officially launched! The seriesincludes FIAflex Fluorescent Immunoassay Analyzer, FIAflex SARS-CoV-2 An...
View Details
NEWS660.png
ACON, a leading global medical device manufacturer, received the Food and Drug Administration (FDA) clearance under the Emergency Use Authorization (EUA) authorization for Acon® SARS-CoV-2 Anti...
View Details
NEWS660.png
ACON announced the results of an independent evaluation of its ACON SARS-CoV-2 IgG/IgM Rapid Test to be published in November. The article, including the results of the independent evaluation, is n...
View Details
Antigen 660.png
We are pleased to announce that the Flowflex SARS-CoV-2 Antigen Rapid Test was officially launched!The Flowflex SARS-CoV-2 Antigen Test is a lateral flow chromatographic immunoassa...
View Details
图片-70_1.png
Good News! The following Nucleic Acid Extraction System is completed of USFDA Device Listing: CLINICAL SAMPLE CONCENTRATOR - PROMOTOR® NES-32 NUCLEIC ACID EXTRACTION SYSTEM; PROMOTOR® N...
View Details
TOP